Gildan Activewear Inc. manufactures and sells various apparel products. It provides various activewear products, including T-shirts, fleece tops and bottoms, and sports shirts, polos, and tank tops under Gildan, Gildan Performance, Gildan Hammer, Gildan Softstyle, Gildan Heavy Cotton, Gildan Ultra Cotton, Gildan DryBlend, Gildan HeavyBlend, Comfort Colors, American Apparel, and Champion brands. The company also offers hosiery products comprising athletic; dress; and casual, liner, therapeutic, and workwear socks under Gildan, GoldToe, Signature Gold by GoldToe, GoldToe Edition, Peds, MediPeds, All Pro, and Powersox brands. In addition, it provides men's and boys' underwear products and ladies panties under Gildan and Gildan Platinum brands. The company sells its products to wholesale distributors, screenprinters, and embellishers in North America, Europe, the Asia-Pacific, and Latin America, as well as to retailers in North America and lifestyle brand companies. The company was formerly known as Textiles Gildan Inc. and changed its name to Gildan Activewear Inc. in March 1995. Gildan Activewear Inc. was founded in 1946 and is headquartered in Montreal, Canada.

Gildan Activewear Inc. Class A Sub. Vot.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Gilead Sciences (GILD) and Alkermes (ALKS) with bull...

Analysts’ Top Healthcare Picks: Gilead Sciences (GILD), Alkermes (ALKS)

Analysts are intrested in these 5 stocks: ( ($SM) ), ( ($CASY) ), ( ($GILD) ), ( ($D) ) and ( ($PODD) ). Here is a breakdown of their recent


SM, Casey’s, Gilead, Dominion, Insulet Trending With Analysts

Jefferies analyst Akash Tewari maintained a Buy rating on Gilead Sciences today and set a price target of $180.00. Tewari covers the Healthcare sec...

Jefferies Remains a Buy on Gilead Sciences (GILD)

Gilead Sciences (($GILD)) has held its Q1 earnings call. Read on for the main highlights of the call. Gilead Sciences’ latest earnings call struck ...

Gilead Sciences Earnings Call Highlights Growth, Deal Drag

Gilat Satellite Networks (($GILT)) has held its Q1 earnings call. Read on for the main highlights of the call. Gilat Satellite Networks’ latest ear...

Gilat Satellite Networks Extends Profitable Growth Streak

Argus Research analyst reiterated a Buy rating on Gilead Sciences on May 15 and set a price target of $165.00. In addition to Argus Research, Gilea...

Argus Research Sticks to Its Buy Rating for Gilead Sciences (GILD)

Last week, stocks pulled back from record highs as oil, yields, and rate fears returned to the forefront. The S&P 500 (SPX) ended at 7,408.50, down...

The Week That Was, The Week Ahead: Macro and Markets, May 17

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Henry Schein (HSIC), Insulet (PODD) and Gilead Scien...

Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC), Insulet (PODD) and Gilead Sciences (GILD)

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Dynatrace (DT) and Gilat (GILT) with bullish sentime...

Analysts Offer Insights on Technology Companies: Dynatrace (DT) and Gilat (GILT)

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Gilat (GILT) and Wix (WIX) with bullish sentiments. ...

Analysts Offer Insights on Technology Companies: Gilat (GILT) and Wix (WIX)

Analysts fell to the sidelines weighing in on Certara (CERT) and Gilead Sciences (GILD) with neutral ratings, indicating that the experts are neith...

Analysts’ Top Healthcare Picks: Certara (CERT), Gilead Sciences (GILD)

In a report released on May 8, Carter Gould from Cantor Fitzgerald maintained a Buy rating on Gilead Sciences, with a price target of $155.00. Acco...

Gilead Sciences (GILD) Receives a Buy from Cantor Fitzgerald

Citi analyst Geoff Meacham maintained a Buy rating on Gilead Sciences on May 7 and set a price target of $165.00. The company’s shares closed last ...

Gilead Sciences (GILD) Receives a Buy from Citi

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Gilead Sciences (GILD), Entrada Therapeutics Inc (TR...

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Entrada Therapeutics Inc (TRDA) and Contineum Therapeutics, Inc. Class A (CTNM)

Truist Financial analyst Gregory Renza reiterated a Buy rating on Gilead Sciences today and set a price target of $157.00. According to TipRanks, R...

Truist Financial Sticks to Their Buy Rating for Gilead Sciences (GILD)

In a report released today, Courtney Breen from Bernstein maintained a Buy rating on Gilead Sciences, with a price target of $160.00. Breen covers ...

Bernstein Remains a Buy on Gilead Sciences (GILD)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vir Biotechnology (VIR), Gilead Sciences (GILD) and ...

Analysts Offer Insights on Healthcare Companies: Vir Biotechnology (VIR), Gilead Sciences (GILD) and Sera Prognostics (SERA)

Gilead Sciences ( ($GILD) ) just unveiled an announcement. At the 2026 annual meeting of stockholders held on April 30, 2026, Gilead Sciences’ inve...

Gilead Shareholders Back Board, Pay Plans at 2026 Meeting

There’s a lot to be optimistic about in the Consumer Cyclical sector as 2 analysts just weighed in on Gildan Activewear (GIL) and Magna Internation...

Wall Street Analysts Are Bullish on Top Consumer Cyclical Picks

Gildan Activewear ( ($TSE:GIL) ) has shared an update. At its hybrid annual meeting of shareholders held in Montreal on April 30, 2026, Gildan Acti...

Gildan Activewear Wins Strong Shareholder Backing at April 30, 2026 AGM

There’s a lot to be optimistic about in the Consumer Cyclical sector as 3 analysts just weighed in on Jack In The Box (JACK), Smurfit Westrock (SW)...

Analysts Offer Insights on Consumer Cyclical Companies: Jack In The Box (JACK), Smurfit Westrock (SW) and Gildan Activewear (GIL)

Analysts have been eager to weigh in on the Consumer Cyclical sector with new ratings on Gildan Activewear (GIL) and Martinrea International (MRETF...

Analysts Conflicted on These Consumer Cyclical Names: Gildan Activewear (GIL) and Martinrea International (OtherMRETF)

Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on Group 1 Automotive (GPI), Dream Finders Hom...

Analysts Offer Insights on Consumer Cyclical Companies: Group 1 Automotive (GPI), Dream Finders Homes (DFH) and Gildan Activewear (GIL)

In a report released today, from Canaccord Genuity reiterated a Buy rating on Gildan Activewear, with a price target of $75.00. In a report release...

Canaccord Genuity Keeps Their Buy Rating on Gildan Activewear (GIL)

Gildan Activewear ( ($TSE:GIL) ) has issued an announcement. Gildan Activewear reported record first quarter 2026 net sales from continuing operati...

Gildan Posts Record Q1 2026 Sales as HanesBrands Integration Drives Scale but Weighs on Profit

Gildan Activewear ( ($TSE:GIL) ) just unveiled an announcement. Gildan Activewear has filed its Form 6-K for April 2026, providing investors with i...

Gildan Activewear Files Q1 2026 Results and Risk Update

There’s a lot to be optimistic about in the Consumer Cyclical sector as 3 analysts just weighed in on DR Horton (DHI), Gildan Activewear (GIL) and ...

Analysts Are Bullish on These Consumer Cyclical Stocks: DR Horton (DHI), Gildan Activewear (GIL)

An update from Gilat ( ($GILT) ) is now available. On April 29, 2026, Gilat Satellite Networks announced that its Gilat Defense division secured an...

Gilat Wins Over $7 Million EnduroStream Defense Contract from U.S. Department of War

There’s a lot to be optimistic about in the Consumer Cyclical sector as 2 analysts just weighed in on Dorman Products (DORM) and Gildan Activewear ...

Market Cap	$10.13B	P/E Ratio	14.09
52W High	$73.70	52W Low	$46.00
Div Yield	99.6%	Payout Ratio	51.8%
EPS Growth 3Y	-3.9%	52W Position	50.1%
Overall Score	63	Value Score	95
Quality Score	50	Technical Score	45

EPS Current Est	$4.25	EPS Next Est	$5.23
EPS Growth Est	+23.1%	DPS Growth 3Y	0.0%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	GIL	$59.87	+2.90%	653.97K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	GIL	$59.87	+2.9%	653.97K
3
4
5
6

GIL

GIL

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Gildan Activewear Inc. Class A Sub. Vot. Data in Excel

Get Gildan Activewear Inc. Class A Sub. Vot. Data in Excel